Skip to main content
Premium Trial:

Request an Annual Quote

Jan Schlüchter

Myriad Genetics announced that Jan Schlüchter will be its new chief commercial officer starting Oct. 15. Schlüchter will lead operations in Europe and guide commercialization efforts around Myriad's tests. In his new role, Schlüchter will report to Gary King, Myriad's executive VP of international operations.

Schlüchter previously held various senior posts at Novartis and most recently was global head of key account management at the firm's headquarters in Basel, Switzerland. Before joining Novartis, Schlüchter was a consultant at McKinsey.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.